208 related articles for article (PubMed ID: 28700392)
1. CD4+/CD8+ ratio restoration in long-term treated HIV-1-infected individuals.
Caby F;
AIDS; 2017 Jul; 31(12):1685-1695. PubMed ID: 28700392
[TBL] [Abstract][Full Text] [Related]
2. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
[TBL] [Abstract][Full Text] [Related]
3. Baseline CD4/CD8 T-Cell Ratio Predicts Prompt Immune Restoration Upon cART Initiation.
Bellissimo F; Pinzone MR; Celesia BM; Cacopardo B; Nunnari G
Curr HIV Res; 2016; 14(6):491-496. PubMed ID: 27074946
[TBL] [Abstract][Full Text] [Related]
4. CD4/CD8 Ratio Recovery of Children and Adolescents Living With HIV With Virological Suppression: A Prospective Cohort Study.
Han WM; Apornpong T; Handoko R; Jantarabenjakul W; Gatechompol S; Ubolyam S; Kerr SJ; Avihingsanon A; Ruxrungtham K; Phanuphak P; Puthanakit T
J Pediatric Infect Dis Soc; 2021 Mar; 10(2):88-96. PubMed ID: 32188991
[TBL] [Abstract][Full Text] [Related]
5. Absolute CD4+ T cell count overstate immune recovery assessed by CD4+/CD8+ ratio in HIV-infected patients on treatment.
Milanés-Guisado Y; Gutiérrez-Valencia A; Trujillo-Rodríguez M; Espinosa N; Viciana P; López-Cortés LF
PLoS One; 2018; 13(10):e0205777. PubMed ID: 30346965
[TBL] [Abstract][Full Text] [Related]
6. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.
Helleberg M; Kronborg G; Ullum H; Ryder LP; Obel N; Gerstoft J
J Infect Dis; 2015 Jun; 211(11):1726-34. PubMed ID: 25489001
[TBL] [Abstract][Full Text] [Related]
7. Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy.
Seng R; Goujard C; Krastinova E; Miailhes P; Orr S; Molina JM; Saada M; Piroth L; Rouzioux C; Meyer L;
AIDS; 2015 Mar; 29(5):595-607. PubMed ID: 25715104
[TBL] [Abstract][Full Text] [Related]
8. Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio.
Hughes RA; May MT; Tilling K; Taylor N; Wittkop L; Reiss P; Gill J; Schommers P; Costagliola D; Guest JL; Lima VD; d'Arminio Monforte A; Smith C; Cavassini M; Saag M; Castilho JL; Sterne JAC
AIDS; 2018 Jun; 32(10):1361-1367. PubMed ID: 29851663
[TBL] [Abstract][Full Text] [Related]
9. Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.
Gras L; May M; Ryder LP; Trickey A; Helleberg M; Obel N; Thiebaut R; Guest J; Gill J; Crane H; Dias Lima V; dʼArminio Monforte A; Sterling TR; Miro J; Moreno S; Stephan C; Smith C; Tate J; Shepherd L; Saag M; Rieger A; Gillor D; Cavassini M; Montero M; Ingle SM; Reiss P; Costagliola D; Wit FWNM; Sterne J; de Wolf F; Geskus R;
J Acquir Immune Defic Syndr; 2019 Mar; 80(3):292-300. PubMed ID: 30531492
[TBL] [Abstract][Full Text] [Related]
10. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
[TBL] [Abstract][Full Text] [Related]
11. CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy.
Okhai H; Vivancos-Gallego MJ; Hill T; Sabin CA
AIDS Res Hum Retroviruses; 2020 Oct; 36(10):808-816. PubMed ID: 32664736
[TBL] [Abstract][Full Text] [Related]
12. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.
Leung V; Gillis J; Raboud J; Cooper C; Hogg RS; Loutfy MR; Machouf N; Montaner JS; Rourke SB; Tsoukas C; Klein MB;
PLoS One; 2013; 8(10):e77665. PubMed ID: 24204912
[TBL] [Abstract][Full Text] [Related]
13. CD4
Vivancos-Gallego MJ; Okhai H; Perez-Elías MJ; Gomez-Ayerbe C; Moreno-Zamora A; Casado JL; Quereda C; Sanz JM; Sanchez-Conde M; Serrano-Villar S; Del Campo S; Dronda F; Galan JC; Sabin CA; Moreno S
Antivir Ther; 2020; 25(2):91-100. PubMed ID: 32338638
[TBL] [Abstract][Full Text] [Related]
14. Determinants of suboptimal CD4
Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.
Ndumbi P; Gillis J; Raboud J; Cooper C; Hogg RS; Montaner JS; Burchell AN; Loutfy MR; Machouf N; Klein MB; Tsoukas C;
HIV Med; 2014 Mar; 15(3):153-64. PubMed ID: 24304582
[TBL] [Abstract][Full Text] [Related]
16. Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4.
Grabar S; Selinger-Leneman H; Abgrall S; Pialoux G; Weiss L; Costagliola D
PLoS One; 2017; 12(10):e0184441. PubMed ID: 28968404
[TBL] [Abstract][Full Text] [Related]
17. Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study.
Hema MN; Ferry T; Dupon M; Cuzin L; Verdon R; Thiébaut R; Protopopescu C; Leport C; Raffi F; Le Moing V;
PLoS One; 2016; 11(8):e0161594. PubMed ID: 27548257
[TBL] [Abstract][Full Text] [Related]
18. Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.
Caby F; Guihot A; Lambert-Niclot S; Guiguet M; Boutolleau D; Agher R; Valantin MA; Tubiana R; Calvez V; Marcelin AG; Carcelain G; Autran B; Costagliola D; Katlama C
Clin Infect Dis; 2016 May; 62(10):1297-1303. PubMed ID: 26908792
[TBL] [Abstract][Full Text] [Related]
19. Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Patients With Human Immunodeficiency Virus Infection and Suppressed Viremia During Long-term Antiretroviral Therapy.
Mutoh Y; Nishijima T; Inaba Y; Tanaka N; Kikuchi Y; Gatanaga H; Oka S
Clin Infect Dis; 2018 Aug; 67(6):927-933. PubMed ID: 29509894
[TBL] [Abstract][Full Text] [Related]
20. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
